Caricamento...
Dihydroartemisinin inhibits the mammalian target of rapamycin-mediated signaling pathways in tumor cells
Dihydroartemisinin (DHA), an antimalarial drug, has previously unrecognized anticancer activity, and is in clinical trials as a new anticancer agent for skin, lung, colon and breast cancer treatment. However, the anticancer mechanism is not well understood. Here, we show that DHA inhibited prolifera...
Salvato in:
| Autori principali: | , , , , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Oxford University Press
2014
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3871936/ https://ncbi.nlm.nih.gov/pubmed/23929438 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/carcin/bgt277 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|